Ropes & Gray Represents Genzyme in Sale of Genzyme Genetics

In The News
September 13, 2010

Ropes & Gray advised Genzyme Corporation in the sale of its Genzyme Genetics business unit to Laboratory Corporation of America Holdings (LabCorp) for $925 million in cash, announced September 13. Under the terms of the agreement, LabCorp will purchase the business in its entirety, including all testing services, technology, intellectual property rights, and its nine testing laboratories.

The Ropes & Gray team was led by Christopher Comeau.